Oslo, 9 November 2020: Ultimovacs ASA (“Ultimovacs”, ticker ULTIMO), a
pharmaceutical company developing novel immunotherapies against cancer, invites
to a webcast presentation of its third quarter 2020 results on Thursday 12
November 2020.
The presentation can be followed as a live webcast (access through link
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201112_4) at 09:00
CET on Thursday 12 November 2020. The webcast presentation will be available on
our website, and it will be possible to post questions during the presentation
through the webcast.
The report and presentation will be available on the company website from 08:00
CET the same day.
For further information, please visit www.ultimovacs.com or contact:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632